Precise lesion formation is crucial for successful
|
|
- Edwina Allison
- 5 years ago
- Views:
Transcription
1 2722 MÜNKLER P et al. Circ J 2018; 82: ORIGINAL ARTICLE doi: /circj.CJ Arrhythmia/Electrophysiology Ablation Index for Catheter Ablation of Atrial Fibrillation Clinical Applicability and Comparison With Force-Time Integral Paula Münkler, MD; Stefan Kröger, PhD; Spyridon Liosis, MD; Amr Abdin, MD; Evgeny Lyan, MD; Charlotte Eitel, MD; Ingo Eitel, MD; Christian Meyer, MD; Stephan Willems, MD; Christian-Hendrik Heeger, MD; Roland Richard Tilz, MD Background: Key determinants for lesion formation in catheter ablation are contact force, radiofrequency (RF) power and time. The aim of this study was to evaluate the clinical applicability of ablation index (AI), a novel non-linear formula based on these components, and to compare AI with the conventional linear force-time interval (FTI) in pulmonary vein isolation (PVI). Methods and Results: Target AI ranges were defined for anatomical segments of the ipsilateral pulmonary veins. The operator was blinded to AI during PVI for the initial 11 patients (group A), and was unblinded for the remaining 23 patients (group B). We assessed (1) the clinical value of AI to avoid excessively high and low values with an operator blinded vs. non-blinded to AI; and (2) the relation of AI and FTI in predefined ranges. In group A, 235/564 lesions (41.7%) were in the predefined target range as compared with 1,171/1,412 lesions (82.9%) in group B (P<0.001). A given AI may correspond to a wide range of FTI, as reflected by a quartile coefficient of dispersion for AI of 0.11 vs. a quartile coefficient of dispersion for FTI of Conclusions: Incorporating RF current power, the non-linear AI provides more comprehensive information during PVI compared with FTI. Given that the FTI for a given AI varies widely, the value of FTI in clinical practice is questionable. Key Words: Atrial fibrillation; Catheter ablation; Contact force; Lesion formation; Pulmonary vein isolation Precise lesion formation is crucial for successful catheter ablation of atrial fibrillation (AF). Key determinants for lesion formation using radiofrequency (RF) ablation are contact force (CF), time and RF power. 1 Insufficient RF delivery may result in ineffective lesion formation, whereas excessive RF current (RFC) delivery may result in potentially life-threatening complications such as atrio-esophageal fistula formation or cardiac tamponade. 2 Reliable and clinically applicable feedback parameters are essential for ablation monitoring and to adequately regulate RF delivery to avoid complications and to keep AF recurrence rates as low as possible. 3 CF and the force-time integral (FTI), the product of CF and ablation time, are the most widely used parameters to control RFC applications. 4 Low CF and FTI during AF ablation are associated with a higher incidence of pulmonary vein (PV) reconnection and recurrence of atrial arrhythmia. 5,6 But even after initially successful PV isolation (PVI), the incidence of reconduction due to gaps in ablation lines is still high. 5,6 CF sensing catheters are now routinely adopted for catheter ablation of cardiac arrhythmias, 7 but FTI has several limitations. First, it does not take into account RF power. The effect of increased power has been shown to be more relevant compared with increased CF. 8 Second, FTI assumes a linear relationship between CF and time. In recent studies, however, the ablation depth graphs reflected a non-linear relationship with time for diverse CF and RF power settings. The novel ablation index (AI; Biosense Webster, Diamond Barr, CA, USA) is intended to overcome these limitations. According to animal models, AI can precisely predict lesion size. 9 AI is a commercially available parameter that combines CF, RF time and RF power in a non-linear formula in real time. It therefore allows for intra-procedural visualization of RFC application in a 3-D electroanatomic mapping Received March 29, 2018; revised manuscript received June 23, 2018; accepted July 17, 2018; released online September 8, 2018 Time for primary review: 26 days University Heart Center Lübeck, Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine), University Hospital Schleswig- Holstein, Lübeck (P.M., S.L., A.A., E.L., C.E., I.E., C.-H.H., R.R.T.); Department of Cardiology - Electrophysiology, University Heart Center Hamburg, University Hospital Hamburg-Eppendorf, Hamburg (P.M., C.M., S.W.); German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Lübeck (I.E.); and Robert Koch Institute, Department Infectious Disease Epidemiology, Unit Respiratory Infections, Berlin (S.K.), Germany Mailing address: Roland Richard Tilz, MD, FEHRA, FESC, FHRS, University Heart Center Lübeck, Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine), University Hospital Schleswig-Holstein, Ratzeburger Allee 160, Lübeck 23538, Germany. tilz6@hotmail.com ISSN All rights are reserved to the Japanese Circulation Society. For permissions, please cj@j-circ.or.jp
2 Ablation Index for PVI 2723 system (Carto 3, Biosense Webster). Recent adoption of AI in clinical practice has produced a significant improvement in procedural outcome 10 and reduced 1-year recurrence rates. 3 In initial clinical studies low AI has been associated with acute and late PV reconduction. 11,12 AI-guided PVI is associated with higher impedance drop and AI is used as a surrogate parameter for effectiveness of lesion formation. 13,14 AI, however, is not yet widely used in clinical practice. Recently, we have adopted the intra-procedural use of the parameter as an institutional standard for RFC ablation of cardiac arrhythmias. In contrast to FTI, target values for AI adapted to the respective atrial segment can be deduced from previous studies. 11 The aim of this study was to (1) assess the clinical utility of AI by comparing AI during PVI with the operator blinded to real-time AI vs. non-blinding of the operator to AI during the procedure, as a retrospective assessment of ablation quality; and (2) compare the widely used FTI with the non-linear AI with respect to distribution. Methods Patients The subjects consisted of 34 patients diagnosed with symptomatic paroxysmal AF defined as >1 episode of AF <7 days duration with 1 episode documented on 12-lead electrocardiogram. 15 Patients with prior left atrial (LA) catheter ablation were excluded. Data were obtained from the institutional ablation registry and analyzed retrospectively. Written informed consent was obtained from all patients. The study was approved by the institutional ethics committee. All patients underwent PVI for paroxysmal AF according to the institutional standard. PVI To exclude LA thrombus, all patients underwent transesophageal echocardiography 1 day prior to the procedure. Intake of novel oral anticoagulation was discontinued 24 h before the procedure. Oral anticoagulation with phenprocoumon was continued and the international normalized ratio was maintained at All patients underwent PVI in deep sedation applying a continuous i.v. infusion of propofol with additional boluses of midazolam and fentanyl. As per the institutional standard, no esophageal temperature monitoring was performed. A decapolar catheter was advanced into the coronary sinus. After double trans-septal puncture, 2 SL1 sheaths were advanced into the LA. A commercially available navigated decapolar spiral mapping catheter (LASSO, Biosense Webster) was used for PV mapping. A 3-D electroanatomic map of the LA was obtained using either a point-by-point technique with a CF-sensing catheter (ThermoCool SmartTouch Surround Flow [STSF], Biosense Webster) or a fast anatomic mapping technique using the spiral catheter. Anatomical segments of the PV were arbitrarily defined as anterior, roof and posterior segments of the ipsilateral PV. Wide area circumferential PVI for treatment of symptomatic paroxysmal AF was performed in power-controlled mode. RFC application was limited to 35 W at the anterior and to 25 W at the roof and posterior segment, respectively, to take into account differing thickness of the myocardial wall and to avoid potential complications such as steam pop formation or esophageal injury. Target AI was 380 for the posterior segment, 450 for the roof segment and 500 for the anterior segment. Table. Patient Characteristics Characteristics Patients (n=34) Age (years) 63.7±11.5 Male 64.7 BMI (kg/m 2 ) 28.3±5.5 CHA2DS2-Vasc score (no. patients) < >4 4 Hypertension 76.5 CAD 32.3 Diabetes mellitus 17.6 COPD 5.9 LVEF (%) 54.5±3.5 LAD (mm) 37.5±3.8 Medication β-adrenergic blocker 85.3 Amiodarone 26.5 ACEI 29.4 Calcium-channel blocker 32.3 Sodium-channel blocker 44.1 Oral anticoagulant Data given as % or mean ± SD, unless otherwise indicated. ACEI, angiotensin-converting enzyme inhibitor; BMI, body mass index; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; LAD, left atrial diameter; LVEF, left ventricular ejection fraction. Importantly, no dragging technique was used. RFC energy was delivered with a target CF of g until a signal reduction of 70% was achieved. Applications <5 s were excluded from analysis. All procedures were performed by 1 single operator. Force-Time Power Index Measurement and Data Acquisition For ablation and AI acquisition we used the STSF catheter (7.5-F sensing catheter with a 3.5-mm irrigated tip, Biosense Webster. Calibration of the catheter was performed before 3-D electroanatomical mapping and thereafter every 20 min. CF was displayed to the operator throughout all procedures. Target range for CF was g. AI was not displayed to the operator for 11 patients (group A) but was registered using the CARTO3 SMARTTOUCH Software (Biosense Webster) module. For each ablation point the following parameters were recorded: ablation time, maximum temperature, maximum CF, maximum power, baseline impedance, impedance drop (defined as minimum impedance subtracted from baseline impedance) and FTI. All data were exported from CARTO3 after the procedure. Settings of the automatic lesion annotation software (Visitag, Biosense Webster) were as follows: stability, 3 mm; minimum CF, 3 g; minimum time, 3s; force over time, 25%. We performed a retrospective analysis of 11 routine PVI procedures (group A; AI blinded) in which AI was recorded but not displayed to the operator. For the prospective cases, AI target values were based on previous clinical studies, 11 and the median values of AI recorded during the blinded cases resulting in target values of 380, 450 and 500 for the posterior, roof and anterior segment, respectively.
3 2724 MÜNKLER P et al. Figure 1. Ablation parameters for procedures where the operator was blinded vs. non-blinded to ablation index (AI) during the procedure. There was no difference between groups for procedural (A) total ablation time [min], (C) maximum contact force [g], (D) maximum temperature [ C], (E) maximum power [W], (F) baseline impedance [Ω] or (G) impedance drop [Ω]. (B) Ablation time per lesion [s], however, was significantly shorter when AI was displayed. During subsequent procedures, AI was displayed to the operator (group B; AI unblinded). RFC delivery was then stopped on reaching AI target thresholds. Ranges of low, optimal, and high AI were defined as target AI±15%. AI values were analyzed according to 3 different anatomical segments of the ipsilateral PV (anterior, posterior and roof). The proportion of AI in the target range was determined for cases with the operator blinded to AI and for cases with AI displayed to the operator. For AI in very low (0 300), low ( ), high ( ), very high ( ) and excessively high (>600) ranges, we assessed the corresponding FTI in order to evaluate the usefulness of AI and FTI in detecting insufficient or excessive RFC delivery. Statistical Analysis Statistical analysis was performed with R (R: A Language and Environment for Statistical Computing, R Core Team, R Foundation for Statistical Computing. Vienna, Austria, Data sets from both patient groups were filtered for a minimal duration of 5 s. Non-normally distributed continuous variables are represented as median (IQR). Kolmogorov-Smirnov test was used to test for normality of distributions. To assess the proportion of values in a target range as a categorical variable, Fisher s exact test was used. Statistical significance was set at P<0.05. To estimate dispersion of non-normally distributed data, the quartile coefficient of dispersion was applied. Pearson correlation coefficient was used for correlation analyses of AI and FTI. Results Thirty-four patients with symptomatic paroxysmal AF were enrolled in the study. Patient characteristics are listed in Table. Procedural Data and Outcome PVI was successfully achieved in all patients and no major periprocedural complication occurred. Mean procedure duration was 144±38 min. Mean dose-area product was 3,070.6±2,034.6 cgy cm 2 and mean radiation duration was 15.5±6.2 min. Median procedure time did not differ between groups: group A, 144 min (IQR, 40 min); group B, 143 min (IQR, 46.5 min; P=0.70). There was no difference in total ablation time, maximum contact force, maximum temperature, baseline impedance or impedance drop between blinded and non-blinded AI (Figure 1). After a mean followup of 639.0±92.9 days, with 1 patient lost to follow-up in group B, the number of recurrences was 4/11 in group A and 7/22 in group B (P=1.0, Fisher s exact test). There were no complications in group A, as opposed to 2 complications in group B (1 post-procedural transitory ischemic attack, 1 groin hematoma not requiring surgical therapy; P=0.54, Fisher s exact test). Blinded vs. Non-Blinded A total of 1,967 ablation points (group A, 564 points, 28.5%; group B, 1,412 points, 71.5%) were included in the analysis. For group A, median AI at the anterior, the posterior and the roof segment was 457 (IQR, ); 426 (IQR, ) and 469 (IQR, ), respectively, for the left PV and 498 (IQR, ); 425 (IQR, ) and 490 (IQR, ), respectively, for the right PV. Median AI in group B (non-blinded) at the anterior, the posterior and the roof segment was 461 (IQR, ); 390 (IQR, ) and 442 (IQR, ), respectively for the left PV
4 Ablation Index for PVI 2725 Figure 2. Proportion of ablation points in the ablation index (AI) target range (±15% of target values, i.e. 500, 380 and 450 for anterior, posterior and roof segment, respectively) when the operator was (Left) blinded or (Right) non-blinded to AI during the procedure. Figure 3. Relation between force-time integral (FTI) and ablation index (AI) when the operator was (A) blinded or (B) non-blinded to AI during the procedure. (B) When AI was displayed, ablation was performed to AI target values of 500 for anterior, 380 for posterior, and 450 for roof segments, resulting in (C, Lower) distinct peaks of AI in the respective segments. (C, Upper) Corresponding FTI does not exhibit distinct peaks, but is widely distributed. (D) Consequently, corresponding FTI for grouped AI has a wider range. and 510 (IQR, ); 381 (IQR, ) and 452 (IQR, ), respectively, for the right PV. Display of AI (group B) resulted in a significantly higher rate of ablation points in the predefined target range as compared with blinded ablation: group A, 235/564 (41.7%) vs. group B, 1,171/1,412 (82.9%; P<0.001), so that very low or very high AI outside the target range were avoided. There was no difference in AI between group A and group B (P=0.631, Wilcoxon test). Median ablation parameters did not differ between groups with respect to ablation time (24.2 min vs min), maximum contact force (19.9 g vs g), maximum temperature (26.9 C vs C), maximum power (25.8 W vs W), baseline impedance (154.0 Ω vs Ω) or impedance drop (7.3 Ω vs. 8.2 Ω).
5 2726 MÜNKLER P et al. Figure 4. Force-time integral (FTI) vs. ablation index (AI) for 2 example lesions demonstrating a wide range of FTI for a given AI. Ablation on the (A) right and (B) left anterior wall until a maximum AI of 550 is reached; the corresponding FTI is (A) 1,098 and (B) 424. Median ablation time per lesion was longer in group A (24.5 s) versus group B (22.0 s; Figure 1). AI below the target range was registered for 90 points (16%), 25 points (4.4%) and 32 points (5.7%) for the anterior, roof and posterior segment, respectively, in group A, and for 97 points (6.9%), 46 points (3.3%) and 35 points (2.5%) for the anterior, roof and posterior segments, respectively, in group B. AI above the target range was registered for 49 points (8.7%), 44 points (7.8%) and 89 points (15.8%) for the anterior, roof and posterior segment, respectively, in group A and for 18 points (1.3%), 16 points (1.1%) and 29 points (2.0%) for the anterior, roof and posterior segment, respectively in group B (Figure 2). AI vs. FTI For very low AI (0 300 AU) FTI ranged from 174 to 512 gs; for low AI ( AU) FTI ranged from 331 to 572 gs; for high AI ( AU), from 357 to 604 gs; for very high AI ( AU) from 215 to 1,220 gs; and for excessively high AI (>600 AU), FTI ranged from 477 to 4,369 gs. AI and FTI did correlate (R=0.70); distinct AI may exhibit a wide range of corresponding FTI (Figure 3). For 74/1,976 points (3.7%) FTI was >400 and AI was below the target range of the respective segment. Generally, FTI varies more widely compared with AI, which is reflected by the quartile coefficient of dispersion, which for AI was 0.11 and 0.36 for FTI. FTI increases linearly whereas AI is characterized by a non-linear growth reflective of lesion formation. 16 Figure 4 shows representative lesions and the increase of FTI and AI over time, illustrating the wide range of FTI for a given AI. Discussion In this study we have demonstrated that AI is a clinically applicable tool that allows for more standardized RFC applications. When compared with the established parameter, the dispersion of FTI is larger, whereas RFC application can easily be adjusted to a narrow range of AI. As demonstrated by Figure 4, FTI increases linearly whereas AI is characterized by a non-linear growth, reflective of lesion formation. Especially for high AI, FTI can vary widely. For CF as a feedback parameter, display of CF resulted in greater stability of the CF values. 17 A higher proportion of AI values were in the target range when AI was displayed to the operator. The ablation parameters ablation time, maximum CF, maximum temperature, maximum power, baseline impedance and impedance drop did not differ between group A and group B, although ablation time per lesion was shorter in group B. Shorter ablation time per lesion may be explained by a more rigorous point-by-point ablation technique. Outcome and complication rates did not differ between the groups, but the sample size was a limited, and hence the study was not sufficiently powered for an assessment of recurrence rates and incidence of complications. A major shortcoming of CF is its high variability related to anatomical and respiration-caused instability, also when visible to the operator. 7,18 In contrast to the corresponding AI ranges, FTI has a large proportion of overlapping values: FTI considered acceptable may correspond to AI in the target range but also to AI below the accepted target range. This demonstrates that FTI may be misleading, notably because high CF can correspond to small lesions. 19 Therefore, when compared with FTI, as an established parameter to control RFC application, AI is more stable and reliable. Similarly to the current findings, impedance drop is a poor predictor of adequate RFC delivery due to its large variability. 1,7 Additionally, for high AI around 500 as recommended for the anterior wall of the LA FTI has a wide dispersion, thereby limiting the clinical applicability of FTI. The principal shortcoming of FTI is its linearity, which does not correspond to the mechanism of lesion formation, which is best approximated in a non-linear formula, incorporating power. 1 These requirements are met by AI, with the respective target values according to the anatomical segment. 11,20 Prevention of low AI has the potential to improve efficacy, whereas avoiding high AI may improve safety. Integration of AI into clinical routine may be useful to achieve more homogeneous lesion formation and allow for more standardized ablation procedures. We therefore suggest the adoption of AI as a real-time feedback parameter as a clinical standard. Study Limitations The present evaluation is a retrospective and observational
6 Ablation Index for PVI 2727 non-randomized study with a limited number of patients. Randomized studies with a larger sample size would be necessary to assess PVI outcome when adopting AI as a procedural feedback tool. In the present study, an assessment of conduction gaps during waiting time or of dormant conduction after PVI was not performed. Conclusions When displayed to the operator, a larger proportion of ablation points are located in the defined target range, thereby avoiding low AI, potentially resulting in ineffective ablation, as well as excessively high AI, potentially resulting in complications such as steam pop formation, cardiac perforation or collateral damages such as atrio-esophageal fistula formation. Given that the non-linear AI incorporates RFC power, it provides more information on lesion formation during PVI compared with the linear FTI formula. AI and FTI do correlate, but, given that the FTI for a given AI ranges widely, the value of linear FTI in clinical practice is questionable. Acknowledgment We would like to thank Marion Stahl and Niklas Scholz for their support with the Carto 3D mapping system. Particularly, we would like to thank Dr. Roza Meyer-Saraei for her support in the management of our institutional database. Disclosures The University Heart Center Hamburg has received a travel grant from Biosense Webster. References 1. Nakagawa H, Jackman WM. The role of contact force in atrial fibrillation ablation. J Atr Fibrillation 2014; 7: Dagres N, Hindricks G, Kottkamp H, Sommer P, Gaspar T, Bode K, et al. Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: Still cause for concern? J Cardiovasc Electrophysiol 2009; 20: Phlips T, Taghji P, El Haddad M, Wolf M, Knecht S, Vandekerckhove Y, et al. Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: The role of interlesion distance, ablation index, and contact force variability in the CLOSE -protocol. Europace 2018; eux376, 4. De Potter T, Van Herendael H, Balasubramaniam R, Wright M, Agarwal SC, Sanders P, et al. Safety and long-term effectiveness of paroxysmal atrial fibrillation ablation with a contact forcesensing catheter: Real-world experience from a prospective, multicentre observational cohort registry. Europace 2018; eux290, 5. Neuzil P, Reddy VY, Kautzner J, Petru J, Wichterle D, Shah D, et al. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: Results from the EFFICAS I Study. Circ Arrhythm Electrophysiol 2013; 6: Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R, et al. EFFICAS II: Optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace 2015; 17: Makimoto H, Lin T, Rillig A, Metzner A, Wohlmuth P, Arya A, et al. In vivo contact force analysis and correlation with tissue impedance during left atrial mapping and catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 2014; 7: Chelu MG, Morris AK, Kholmovski EG, King JB, Kaur G, Silver MA, et al. Durable lesion formation while avoiding esophageal injury during ablation of atrial fibrillation: Lessons learned from late gadolinium MR imaging. J Cardiovasc Electrophysiol 2018; 29: Koruth JS, Iwasawa J, Enomoto Y, Bar-Tal M, Ultchin Y, Sigal A, et al. Chamber-specific radiofrequency lesion dimension estimation using novel catheter-based tissue interface temperature sensing. JACC Clin Electrophysiol 2017; 3: Hussein A, Das M, Chaturvedi V, Asfour IK, Daryanani N, Morgan M, et al. Prospective use of ablation index targets improves clinical outcomes following ablation for atrial fibrillation. J Cardiovasc Electrophysiol 2017; 28: Das M, Loveday JJ, Wynn GJ, Gomes S, Saeed Y, Bonnett LJ, et al. Ablation index, a novel marker of ablation lesion quality: Prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values. Europace 2016; 19: El Haddad M, Taghji P, Phlips T, Wolf M, Demolder A, Choudhury R, et al. Determinants of acute and late pulmonary vein reconnection in contact force-guided pulmonary vein isolation. Circ Arrhythm Electrophysiol 2017; 10: e Hussein AA, Barakat AF, Salimba WI, Tarakji KG, Bassiouny M, Baranowski B, et al. Persistent atrial fibrillation ablation with or without contact force sensing. J Cardiovasc Electrophysiol 2017; 28: Ullah W, Hunter RJ, Finlay MC, McLean A, Dhinoja MB, Sporton S, et al. Ablation index and surround flow catheter irrigation. JACC Clin Electrophysiol 2017; 3: Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. J Interv Card Electrophysiol 2017; 50: Nath S, Haines DE. Biophysics and pathology of catheter energy delivery systems. Prog Cardiovasc Dis 1995; 37: Makimoto H, Heeger CH, Lin T, Rillig A, Metzner A, Wissner E, et al. Comparison of contact force-guided procedure with non-contact force-guided procedure during left atrial mapping and pulmonary vein isolation: Impact of contact force on recurrence of atrial fibrillation. Clin Res Cardiol 2015; 104: Shah DC, Lambert H, Nakagawa H, Langenkamp A, Aeby N, Leo G. Area under the real-time contact force curve (force-time integral) predicts radiofrequency lesion size in an in vitro contractile model. J Cardiovasc Electrophysiol 2010; 21: Calzolari V, De Mattia L, Indiani S, Crosato M, Furlanetto A, Licciardello C, et al. In vitro validation of the lesion size index to predict lesion width and depth after irrigated radiofrequency ablation in a porcine model. JACC Clin Electrophysiol 2017; 3: Chikata A, Kato T, Sakagami S, Kato C, Saeki T, Kawai K, et al. Optimal force-time integral for pulmonary vein isolation according to anatomical wall thickness under the ablation line. J Am Heart Assoc 2016; 5: e
Mapping and Ablation in AF: how can we evaluate the lesion formation?
Innovative Cardiac Arrhythmias solutions in only one technology Venice Arrhythmias 17 Oct 2015 Mapping and Ablation in AF: how can we evaluate the lesion formation? Dhiraj Gupta MD DM FRCP Consultant Cardiologist
More informationRaphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center
Radiofrequency Ablation of Atrial Fibrillation: Comparison of Success Rate of Circular Ablation vs Point-by-Point Ablation with Contact Force Assessment in Paroxysmal and Persistent Atrial Fibrillation
More informationAblation Index : A new standard for Safety and Efficacy. Dr Franck Halimi Hôpital Privé Parly 2 Le Chesnay, France
Ablation Index : A new standard for Safety and Efficacy Dr Franck Halimi Hôpital Privé Parly 2 Le Chesnay, France Disclosures Dr Franck Halimi... I have the following potential conflicts of interest to
More informationAblation Lesion Assessment
HRC 2016 Ablation Lesion Assessment The creation of effective and permanent lesions Ian Wright Imperial College Healthcare Wed 09:00-09:30 Hall 11 Objective Examine the role of existing strategies and
More informationCatheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P.
Ioannina 2015 Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method Konstantinos P. Letsas, MD, FESC SECOND DEPARTMENT OF CARDIOLOGY LABORATORY
More informationΚατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.
Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ» Rhythm control antiarrhythmic drugs vs catheter ablation Summary
More informationCatheter Ablation of Long-Standing Persistent Atrial Fibrillation
Journal of the American College of Cardiology Vol. 60, No. 19, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.04.060
More informationPulmonary vein isolation (PVI) has become the cornerstone. Original Article
Original Article In Vivo Contact Force Analysis and Correlation With Tissue Impedance During Left Atrial Mapping and Catheter Ablation of Atrial Fibrillation Hisaki Makimoto, MD, PhD; Tina Lin, MD; Andreas
More informationA Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC
A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC AF Clinical/Referral Challenge Asymptomatic 40% 3 Rx Effective 30% Failed Rx Ablation Atrial fibrillation (AF) is the most common Candidate
More informationSince pulmonary veins (PVs) have
Case Report Hellenic J Cardiol 2011; 52: 371-376 Left Atrial-Pulmonary Vein Reentrant Tachycardia Following Pulmonary Vein Isolation Dionyssios Leftheriotis, Feifan Ouyang, Karl-Heinz Kuck II. Med. Abteilung,
More informationInitial Experience Using AutoMark in Atrial Fibrillation Ablation
83 EJCM 2018; 06 (3): 83-88 Doi: 10.32596/ejcm.18.00383 Initial Experience Using AutoMark in Atrial Fibrillation Ablation Krasimir R. Dzhinsov 1, Tosho L. Balabanski 2 1) St. George University Hospital
More informationIntroduction. CLINICAL RESEARCH Ablation for atrial fibrillation
Europace (217) 19, 775 783 doi:1.193/europace/euw15 CLINICAL RESEARCH Ablation for atrial fibrillation Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection
More informationPulmonary Vein Isolation for AF RF or Cryo? Dr. Yuen Ho Chuen Princess Margaret Hospital
Pulmonary Vein Isolation for AF RF or Cryo? Dr. Yuen Ho Chuen Princess Margaret Hospital PV as a Source of Ectopic Activity Haissaguerre, et al. NEJM 1998 RF Ablation Gold standard Point by point ablation
More informationPercutaneous Transvenous Atrial Fibrillation Ablation and Stroke
Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke Vivek Y. Reddy, MD Helmsley Trust Professor of Medicine Director, Cardiac Arrhythmia Service The Mount Sinai Hospital Disclosures Grant
More informationThe Future of Catheter Ablation
The Future of Catheter Ablation KH Kuck, MD Asklepios Klink St. Georg, Hamburg Disclosure Statement Research Grants Consultant / Advisory Board Ownership Interests Speaker s Bureau Honoraria Biosense Webster,
More informationΕπιπλοκές κατάλυσης πνευµονικών φλεβών
Επιπλοκές κατάλυσης πνευµονικών φλεβών Παναγιώτης Ιωαννίδης Διευθυντής Τµήµατος Αρρυθµιών & Επεµβατικής Ηλεκτροφυσιολογίας Βιοκλινικής Αθηνών ΣΕΜΙΝΑΡΙΑ ΟΜΑΔΩΝ ΕΡΓΑΣΙΑΣ Ιωάννινα, 27-2-2015 Solving an equation
More information974 ZUCCHELLI G et al. Circ J 2018; 82: ORIGINAL ARTICLE doi: /circj.CJ
974 ZUCCHELLI G et al. Circ J 2018; 82: 974 982 ORIGINAL ARTICLE doi: 10.1253/circj.CJ-17-0421 Arrhythmia/Electrophysiology Contiguity Between Ablation Lesions and Strict Catheter Stability Settings Assessed
More informationNew technology to minimize radiation
Room 103-104 15/April/2016 New technology to minimize radiation Jun Kim University of Ulsan College of Medicine Asan Medical Center Heart Institute Disclosure NONE I have no experience using Carto Univu
More informationNew Parameter to Predict Recurrence of Paroxysmal Atrial Fibrillation after Pulmonary Vein Isolation by the P-Wave Signal-Averaged Electrocardiogram
Showa Univ J Med Sci 29 2, 141 150, June 2017 Original New Parameter to Predict Recurrence of Paroxysmal Atrial Fibrillation after Pulmonary Vein Isolation by the P-Wave Signal-Averaged Electrocardiogram
More informationDespite significant improvements in catheter ablation. Original Article
Original Article Electrical Reconnection After Pulmonary Vein Isolation Is Contingent on Contact Force During Initial Treatment Results From the EFFICAS I Study Petr Neuzil, MD, PhD; Vivek Y. Reddy, MD;
More informationCatheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD
Catheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD Taipei Veterans General Hospital, Taiwan Outline of AF Ablation 1. Strategy for Catheter Ablation of AF 2. Substrate
More informationJACC: CLINICAL ELECTROPHYSIOLOGY VOL. 3, NO. 10, 2017 ª 2017 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION
ª 2017 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION PUBLISHED BY ELSEVIER ISSN 2405-500X/$36.00 http://dx.doi.org/10.1016/j.jacep.2017.08.016 In Vitro Validation of the Lesion Size Index to Predict
More information480 April 2004 PACE, Vol. 27
Incremental Value of Isolating the Right Inferior Pulmonary Vein During Pulmonary Vein Isolation Procedures in Patients With Paroxysmal Atrial Fibrillation HAKAN ORAL, AMAN CHUGH, CHRISTOPH SCHARF, BURR
More informationLong Standing Persistent AF ; CPVI is enough for it
Long Standing Persistent AF ; CPVI is enough for it Kee-Joon Choi, MD University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea Boston AF Symposium 2012 In a patient undergoing AF ablation
More informationCombined catheter ablation and left atrial appendage closure as a. treatment of atrial fibrillation
Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation Giulio Molon, MD FACC, FESC, Fellow ANMCO Card Dept, S.Cuore hospital Negrar
More informationTime to recurrence of atrial fibrillation influences outcome following catheter ablation
Time to recurrence of atrial fibrillation influences outcome following catheter ablation Larraitz Gaztañaga, MD, David S. Frankel, MD, Maria Kohari, MD, Lavanya Kondapalli, MD, Erica S. Zado, PA-C, FHRS,
More informationAtrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States
Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States Srinivas R. Dukkipati, MD Co-Director, Cardiac Arrhythmia Service The Mount
More informationDespite significant improvements in catheter ablation. Original Article
Original Article Electrical Reconnection After Pulmonary Vein Isolation Is Contingent on Contact Force During Initial Treatment Results From the EFFICAS I Study Petr Neuzil, MD, PhD; Vivek Y. Reddy, MD;
More informationLinear Ablation Should Not Be a Standard Part of Ablation in Persistent AF. Disclosures. LA Ablation vs. Segmental Ostial Ablation With PVI for PAF
Linear Ablation Should Not Be a Standard Part of Ablation in Persistent AF The CA Heart Rhythm Symposium September 7, 2012 Gregory K. Feld, MD Professor of Medicine Director, Cardiac EP Program University
More informationOriginal Article Pulmonary vein isolation without left atrial mapping
www.ipej.org 142 Original Article Pulmonary vein isolation without left atrial mapping Attila Kardos MD 1, Csaba Foldesi MD 1, Karoly Ladunga MSc, PhD 1, Attila Toth MD 2, Tamas Szili-Torok MD, PhD 1 1
More informationOriginal Article. . Compared with segments without PVR (n=758), PVR segments (n=44) were characterized by lower Δ-Imp min. , ILD max.
Original Article Determinants of Acute and Late Pulmonary Vein Reconnection in Contact Force Guided Pulmonary Vein Isolation Identifying the Weakest Link in the Ablation Chain Milad El Haddad MSc PhD;
More informationAtrial Fibrillation Ablation: in Whom and How
Update on Consensus Statement on Management of Atrial Fibrillation: EHRA 2012 Atrial Fibrillation Ablation: in Whom and How Update of HRS/EHRA AF/ECAS Ablation Document 2012 Anne M Gillis MD FHRS Professor
More informationCatheter Ablation: Atrial fibrillation (AF) is the most common. Another Option for AF FAQ. Who performs ablation for treatment of AF?
: Another Option for AF Atrial fibrillation (AF) is a highly common cardiac arrhythmia and a major risk factor for stroke. In this article, Dr. Khan and Dr. Skanes detail how catheter ablation significantly
More informationIndicatie voor ablatie bij voorkamerfibrillatie. Andrea Sarkozy Cardiologie Universitair Ziekenhuis Antwerpen
Indicatie voor ablatie bij voorkamerfibrillatie Andrea Sarkozy Cardiologie Universitair Ziekenhuis Antwerpen Definition and Classification of AF - Practical aspects Classification of AF Paroxysmal, persistent,
More information20% 10/9/2018. Fluoroless Ablation relinquishing an old habit. Prevalence of Atrial Fibrillation. Atrial Fibrillation is a Progressive Disease
Fluoroless Ablation relinquishing an old habit Robert Percell, MD, FACC Cardiac Electrophysiologist, Bryan Heart Institute Lincoln, NE Prevalence of Atrial Fibrillation 3.1 Million + 1 Million by 2020
More informationCatheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes
Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Francis Marchlinski, MD Richard T and Angela Clark President s Distinguished Professor Director Cardiac Electrophysiolgy University
More informationMechanism of Immediate Recurrences of Atrial Fibrillation After Restoration of Sinus Rhythm
Mechanism of Immediate Recurrences of Atrial Fibrillation After Restoration of Sinus Rhythm AMAN CHUGH, MEHMET OZAYDIN, CHRISTOPH SCHARF, STEVE W.K. LAI, BURR HALL, PETER CHEUNG, FRANK PELOSI, JR, BRADLEY
More informationIs cardioversion old hat? What is new in interventional treatment of AF symptoms?
Is cardioversion old hat? What is new in interventional treatment of AF symptoms? Joseph de Bono Consultant Electrophysiologist University Hospitals Birmingham Atrial Fibrillation (AF) Affects 2% of the
More informationIntegration of CT and fluoroscopy images in the ablative treatment of atrial fibrillation
Clinical applications Integration of CT and fluoroscopy images in the ablative treatment of atrial fibrillation C. Kriatselis M. Tang M. Roser J-H. erds-li E. leck Department of Internal Medicine/Cardiology,
More informationOutcomes of AF Ablation
2017 춘계심혈관통합학술대회 AF Summit: Atrial Fibrillation Apr.21(Fri) 14:40-16:10 Rm.300B 15:00-15:10 Outcomes of AF Ablation Gi-Byoung Nam MD Asan Medical Center, UUCM 2017 Annual Spring Scientific Conference of
More informationCLINICAL COMPENDIUM. The HeartLight Endoscopic Ablation System Putting a New Level of PVI Precision Close at Hand. CardioFocus.com
CLINICAL COMPENDIUM The HeartLight Endoscopic Ablation System Putting a New Level of PVI Precision Close at Hand CardioFocus.com Published results noted below may include references to both on-label and
More informationFibrillation Atriale Paroxystique : ablation, résultats, complications
Fibrillation Atriale Paroxystique : ablation, résultats, complications DIU Rythmologie Paris, le 27/01/16 sboveda@clinique-pasteur.com 1 A disease with bad consequences RR de patients en FA comparé avec
More informationAF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT
AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT 5-2014 Atrial Fibrillation therapeutic Approach Rhythm Control Thromboembolism Prevention: Recommendations Direct-Current
More informationCatheter ablation of AF Where do we stand, where do we go?
Catheter ablation of AF Where do we stand, where do we go? Sébastien Knecht MD, PhD Hôpital cardiologique du Haut L Evêque, Bordeaux Declaration of conflict of interest ABLATION STRATEGIES Duration proc:
More informationUNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate
KPAF trial The Kansai Plus Atrial Fibrillation (KPAF) trial is a 2x2 factorial randomized controlled trial, composed of the UNDER-ATP and EAST-AF trials. Efficacy of adenosine triphosphate guided ablation
More informationAtrial fibrillation (AF), the most sustained cardiac arrhythmia
Difference Between Dormant Conduction Sites Revealed by Adenosine Triphosphate Provocation and Unipolar Pace-Capture Sites Along the Ablation Line After Pulmonary Vein Isolation Rikitake Kogawa, 1 MD,
More informationClinical Value of Noninducibility by High-Dose Isoproterenol Versus Rapid Atrial Pacing After Catheter Ablation of Paroxysmal Atrial Fibrillation
13 Clinical Value of Noninducibility by High-Dose Isoproterenol Versus Rapid Atrial Pacing After Catheter Ablation of Paroxysmal Atrial Fibrillation THOMAS CRAWFORD, M.D., AMAN CHUGH, M.D., ERIC GOOD,
More informationAblation of persistent AF Is it different than paroxysmal?
Ablation of persistent AF Is it different than paroxysmal? Steven J. Kalbfleisch, MD Medical Director Electrophysiology Laboratory Ohio State University Wexner Medical Center Ross Heart Hospital Columbus,
More informationThe impact of hypertension on the electromechanical properties and outcome of catheter ablation in atrial fibrillation patients
Original Article The impact of hypertension on the electromechanical properties and outcome of catheter ablation in atrial fibrillation patients Tao Wang 1, Yun-Long Xia 1, Shu-Long Zhang 1, Lian-Jun Gao
More informationCatheter-Induced Linear Lesions in the Left Atrium in Patients With Atrial Fibrillation An Electroanatomic Study
Journal of the American College of Cardiology Vol. 42, No. 7, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00940-9
More informationRuolo della ablazione della fibrillazione atriale nello scompenso cardiaco
Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco Matteo Anselmino Division of Cardiology Città della Salute e della Scienza Hospital University of Turin, Italy Disclosure: Honoraria
More informationInterventional solutions for atrial fibrillation in patients with heart failure
Interventional solutions for atrial fibrillation in patients with heart failure Advances in Cardiovascular Arrhythmias Great Innovations in Cardiology Matteo Anselmino, MD PhD Division of Cardiology Department
More informationElectrical Reconnection Following PVI is Contingent on Contact Force during Initial Treatment Results From the EFFICAS I Study
Electrical Reconnection Following PVI is Contingent on Contact Force during Initial Treatment Results From the EFFICAS I Study Running title: Neuzil et al.; EFFICAS I contact force predicts gaps in PVI
More informationA MULTIDISCIPLINARY APPROACH TO ATRIAL FIBRILLATION: OUR EXPERIENCE WITH THE CONVERGENT PROCEDURE
A MULTIDISCIPLINARY APPROACH TO ATRIAL FIBRILLATION: OUR EXPERIENCE WITH THE CONVERGENT PROCEDURE Joe Aoun, MD Ioannis Koulouridis, MD, MSc Aleem Mughal, MD Maxwell Eyram Afari, MD Caroline Zahm, MD John
More information1596 TANAKA N et al. Circ J 2017; 81: ORIGINAL ARTICLE doi: /circj.CJ
1596 TANAKA N et al. Circ J 2017; 81: 1596 1602 ORIGINAL ARTICLE doi: 10.1253/circj.CJ-17-0195 Arrhythmia/Electrophysiology Automated Ablation Annotation Algorithm Reduces Re-conduction of Isolated Pulmonary
More informationSurgical Ablation for Lone AF: What have we learned after 30 years?
Surgical Ablation for Lone AF: What have we learned after 30 years? Ralph J. Damiano, Jr., MD Evarts A. Graham Professor of Surgery Chief of Cardiothoracic Surgery Vice Chairman, Department of Surgery
More informationThe EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On?
The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On? L. Pison, MD PhD FESC AATS Surgical Treatment of Arrhythmias and Rhythm Disorders November 17-18, 2017 Miami Beach, FL, USA
More informationRadiation dose is significantly reduced by use of contact force sensing catheter during circumferential pulmonary vein isolation
Radiation dose is significantly reduced by use of contact force sensing catheter during circumferential pulmonary vein isolation Giuseppe Stabile, MD 1, Antonio De Simone, MD 2, Francesco Solimene, MD
More informationAnkara, Turkey 2 Department of Cardiology, Division of Arrhythmia and Electrophysiology, Yuksek Ihtisas
258 Case Report Electroanatomic Mapping-Guided Radiofrequency Ablation of Adenosine Sensitive Incessant Focal Atrial Tachycardia Originating from the Non-Coronary Aortic Cusp in a Child Serhat Koca, MD
More informationThe influence of varying energy settings on efficacy and safety of endoscopic pulmonary vein isolation
The influence of varying energy settings on efficacy and safety of endoscopic pulmonary vein isolation Andreas Metzner, MD,* Erik Wissner, MD, FHRS,* Bas Schoonderwoerd, MD,* Andre Burchard, MD, Roland
More informationSupplementary Online Content
Supplementary Online Content Morillo CA, Verma A, Connolly SJ, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2): a randomzied clinical
More informationContact force and force-time integral in atrial radiofrequency ablation predict transmurality of lesions
Europace (214) 16, 66 667 doi:1.193/europace/euu68 CLINICAL RESEARCH Ablation for atrial fibrillation Contact force and force-time integral in atrial radiofrequency ablation predict transmurality of lesions
More informationCatheter Ablation of Atrial Fibrillation
Cardiology Update 2011 Catheter Ablation of Atrial Fibrillation Laurent Haegeli University Hospital Zurich February 16, 2011 Willem Einthoven and Sir Thomas Lewis The first ECG in 1903 Willem Einthoven
More informationOesophageal temperature monitoring and incidence of oesophageal lesions after pulmonary vein isolation using a remote robotic navigation system
Europace (2010) 12, 655 661 doi:10.1093/europace/euq061 CLINICAL RESEARCH Ablation for Atrial Fibrillation Oesophageal temperature monitoring and incidence of oesophageal lesions after pulmonary vein isolation
More informationAtrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology
Atrial Fibrillation: Rate vs. Rhythm Michael Curley, MD Cardiac Electrophysiology I have no relevant financial disclosures pertaining to this topic. A Fib Epidemiology #1 Most common heart rhythm disturbance
More informationNICE has also published a medtech innovation briefing on the TactiCath Quartz catheter.
pat hways ThermoCool SmartTouch catheter for percutaneous radiofrequency ablation in atrial fibrillation Medtech innovation briefing Published: 23 March 2016 nice.org.uk/guidance/mib61 Summary ThermoCool
More information3/25/2017. Program Outline. Classification of Atrial Fibrillation
Alternate Strategies to Antiarrhythmic Therapy: The Role of Ablation Jennifer El Aile, MS, AGPCNP-BC Electrophysiology Nurse Practitioner Clinical Lecturer at the University of Michigan Program Outline
More informationPeri-Mitral Atrial Flutter with Partial Conduction Block between Left Atrium and Coronary Sinus
Accepted Manuscript Peri-Mitral Atrial Flutter with Partial Conduction Block between Left Atrium and Coronary Sinus Ryota Isogai, MD, Seiichiro Matsuo, MD, Ryohsuke Narui, MD, Shingo Seki, MD;, Michihiro
More informationImpact of Atrial Fibrillation Termination Site and Termination Mode in Catheter Ablation on Arrhythmia Recurrence
78 MIYAZAKI S et al. Circulation Journal ORIGINAL ARTICLE Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Arrhythmia/Electrophysiology Impact of Atrial Fibrillation Termination
More informationCardiovascular Surgery and Electrophysiology: Where are the opportunities for a Combined Interdisciplinary approach in Atrial Fibrillation?
Cardiovascular Surgery and Electrophysiology: Where are the opportunities for a Combined Interdisciplinary approach in Atrial Fibrillation? Felix Yang, MD, FACC, FHRS, CCDS Associate Director, Cardiac
More informationDr Mark Earley MD FRCP Consultant Cardiologist
Dr Mark Earley MD FRCP Consultant Cardiologist PERSONAL DETAILS ADDRESS (NHS) (Private practice) Dominion House, St Olaf House, St Bartholomew s London Bridge Hospital Hospital, 27 Tooley Street, London,
More informationComplex Left Atrial (CLA) Best Practices for Navigant
Complex Left Atrial (CLA) Best Practices for Navigant Ischemic Ventricular Tachycardia (VT) Best Practices for Navigant Ischemic VT Ablation Procedures Set Up In the absence of a septal defect or other
More informationThe HISTORIC-AF TRIAL
European Prospective Multicenter Study of Hybrid Thoracoscopic and Transcatheter Ablation of Persistent Atrial Fibrillation: The HISTORIC-AF TRIAL Claudio Muneretto 1, Gianluigi Bisleri 1, Gianluca Polvani
More informationWhat s new in my specialty?
What s new in my specialty? Jon Melman, MD Heart Rhythm Specialists McKay-Dee Hospital some would say some would say my specialty 1 some would say my specialty First pacemaker 1958 some would say my specialty
More informationCatheter Ablation of Atrial Fibrillation in Patients with Prosthetic Mitral Valve
Catheter Ablation of Atrial Fibrillation in Patients with Prosthetic Mitral Valve Luigi Di Biase, MD, PhD, FHRS Senior Researcher Texas Cardiac Arrhythmia Institute at St. David s Medical Center, Austin,
More informationErik Wissner, MD, F.A.C.C. Asklepios Klinik St. Georg Hamburg, Germany on behalf of the VTACH Study group
Impact of Inducibility of VT during Ablation and Acute Success of Catheter Ablation on Survival Free from VT/VF and ICD Shocks: Lessons from the VTACH Study Erik Wissner, MD, F.A.C.C. Asklepios Klinik
More informationThe Who, What, Why, and How-To Guide for Circumferential Pulmonary Vein Ablation
1226 TECHNIQUES AND TECHNOLOGY Editor: Hugh Calkins, M.D. The Who, What, Why, and How-To Guide for Circumferential Pulmonary Vein Ablation CARLO PAPPONE, M.D., PH.D., and VINCENZO SANTINELLI, M.D. From
More informationCLINICAL COMPENDIUM. The HeartLight Endoscopic Ablation System Putting a New Level of PVI Precision Close at Hand. CardioFocus.com
CLINICAL COMPENDIUM The HeartLight Endoscopic Ablation System Putting a New Level of PVI Precision Close at Hand CardioFocus.com Published results summarized in this compendium may include references to
More informationJay Simonson, MD, FACC, FHRS Medical Director, Cardiac Electrophysiology Park Nicollet Heart and Vascular Center
Jay Simonson, MD, FACC, FHRS Medical Director, Cardiac Electrophysiology Park Nicollet Heart and Vascular Center A-Fib Facts Yes, you may be able to blame your parents It is more of a nuisance than a
More informationProf. Samir Morcos Rafla Alexandria Univ. Cardiology Dept.
Obesity as a risk factor for Atrial Fibrillation Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept. CardioAlex 2010 smrafla@hotmail.com 1 Obesity has reached epidemic proportions in the United
More informationAtrial fibrillation (AF) is a disorder seen
This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,
More informationDevices to Protect Against Stroke in Atrial Fibrillation
Devices to Protect Against Stroke in Atrial Fibrillation Jonathan C. Hsu, MD, MAS Associate Clinical Professor Division of Cardiology, Section of Cardiac Electrophysiology June 2, 2018 Disclosures Honoraria
More informationAF Today: W. For the majority of patients with atrial. are the Options? Chris Case
AF Today: W hat are the Options? Management strategies for patients with atrial fibrillation should depend on the individual patient. Treatment with medications seems adequate for most patients with atrial
More informationESSA HEART AND VASCULAR INSTITUTE APR/MAY/JUNE 2009 CLINICAL LETTER
CLINICAL LETTER Exciting things are happening at the ESSA Heart and Vascular Institute and the Pocono Medical Center! We are all proud of the stellar team of professionals who are working very hard to
More informationOriginal Article Short- and long-term experience in pulmonary vein segmental ostial ablation for paroxysmal atrial fibrillation*
www.ipej.org 6 Original Article Short- and long-term experience in pulmonary vein segmental ostial ablation for paroxysmal atrial fibrillation* *English version of "Langzeit-Ergebnisse der ostialen Pulmonalvenenisolation
More informationFA et Apnée du Sommeil
FA et Apnée du Sommeil La Réunion Octobre 2017 Pascal Defaye CHU Grenoble-Alpes Obstructive Sleep Apnea and AF Incidence of atrial fibrillation (AF), based on presence or absence of OSA. Cumulative frequency
More informationThe pulmonary veins have been demonstrated to often
Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation Hakan Oral, MD; Bradley P. Knight, MD; Hiroshi Tada, MD; Mehmet Özaydın, MD; Aman Chugh, MD; Sohail Hassan, MD; Christoph Scharf,
More informationIn Whom and When Should Atrial Fibrillation Ablation be Considered?
In Whom and When Should Atrial Fibrillation Ablation be Considered? Christian de Chillou, MD, PhD Department of Cardiology University Hospital Nancy, France ESC 2010 Stockholm, August 30. 2010 2 In Whom?
More informationעדכונים באלקטרופיזיולוגיה Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev
עדכונים באלקטרופיזיולוגיה 2014 Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev 1 מבנה הצגת היחידה פעילות ביחידה סקירה על הטיפול באלקטרופיזיולוגיה
More informationRadiofrequency Energy: Irrigation and Alternate Catheters. Andreas Pflaumer
Radiofrequency Energy: Irrigation and Alternate Catheters Andreas Pflaumer Irrigated tip RF ablation Irrigated tip How does it work? Potential benefits? Potential risks? How is this relevant to pediatric
More informationAdvance Publication by-j-stage. Low Risk of Pulmonary Vein Stenosis After Contemporary Atrial Fibrillation Ablation
Circ J doi: 10.1253/circj.CJ-17-1324 Advance Publication by-j-stage ORIGINAL ARTICLE Arrhythmia/Electrophysiology Low Risk of Pulmonary Vein Stenosis After Contemporary Atrial Fibrillation Ablation Lessons
More informationCatheter ablation: the recovery process and what to expect
Catheter ablation: the recovery process and what to expect Mark O Neill DPhil FRCP FHRS Consultant Cardiologist & Professor of Cardiac Electrophysiology Division of Imaging and Biomedical Engineering &
More informationTrigger Activity More Than Three Years After Left Atrial Linear Ablation Without Pulmonary Vein Isolation in Patients With Atrial Fibrillation
Journal of the American College of Cardiology Vol. 46, No. 2, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.03.063
More informationIntroduction. Methods
Europace (2015) 17, 801 806 doi:10.1093/europace/euu332 CLINICAL RESEARCH Cardiac electrophysiology Electrophysiological studies in patients with paroxysmal supraventricular tachycardias but no electrocardiogram
More informationUniversity of Groningen. Ablation of atrial fibrillation de Maat, Gijs Eduard
University of Groningen Ablation of atrial fibrillation de Maat, Gijs Eduard IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationΣτροφείς (rotors) και πραγματικότητα. Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ»
Στροφείς (rotors) και πραγματικότητα. Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ» Mechanisms that sustain Atrial Fibrillation multiwavelet hypothesis, since 1964 a critical
More informationComplications During Cardiovascular Interventions: Management and Prevention
Complications During Cardiovascular Interventions: Management and Prevention Helmut Pürerfellner, MD Public Hospital Elisabethinen Academic Teaching Hospital Linz, Austria Atrial Tachycardia/Atypical left
More informationCARDIOINSIGHT TM NONINVASIVE 3D MAPPING SYSTEM CLINICAL EVIDENCE SUMMARY
CARDIOINSIGHT TM NONINVASIVE 3D MAPPING SYSTEM CLINICAL EVIDENCE SUMMARY April 2017 SUPPORTING EVIDENCE RHYTHM AF VT PUBLICATIONS Driver Domains in Persistent Atrial Fibrillation (Haissaiguerre, et al)
More informationIntroduction. Material and methods
Europace (2014) 16, 1679 1683 doi:10.1093/europace/eut351 BASIC SCIENCE Characterization of the impact of catheter tissue contact force in lesion formation during cavo-tricuspid isthmus ablation in an
More informationSupplementary Online Content
Supplementary Online Content Verma A, Champagne J, Sapp J, et al. Asymptomatic episodes of atrial fibrillation before and after catheter ablation: a prospective, multicenter study. JAMA Intern Med. Published
More information